Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  MedicationBG ControlType 1 DiabetesMedical DevicesInsulinGlucose MonitoringIssue 731

AACE: New Guidance on Insulin Pumps

In order for a patient to obtain maximum benefit from an insulin pump, uniform training programs must be developed.... 

Advertisement

George Grunberger, MD, president of AACE stated in an updated consensus statement that, "The organization acknowledges that pumps have become more sophisticated, and in order to obtain maximum benefit, training programs should be developed." According to that statement, which was published in Endocrine Practice, an update to earlier guidance from 2010 offered recommendations for patients who are on pump therapy with both type 1 and type 2 diabetes. It addresses the benefits of pump therapy, which include: pump therapy has benefits over multiple daily injections, better outcomes in regards to glycemic control, quality of life improvements, and severe hypoglycemia reductions.

The guidance provides an update on the state of technology and improvements to functional features of the pump. These improvements can be maximized if providers offer comprehensive training programs to patients.

Dr. Grunberger made several recommendations for creating a uniform training program including that the right people should be on the pumps and the people on pump therapy should be trained well. Some of the challenges in using pump therapy were also outlined including one of the biggest, that Medicare no longer covers CGM for pump therapy in patients over 65.

Practice Pearls:
  • Pump therapy has benefits over multiple daily injections, better outcomes in regards to glycemic control, quality of life improvements, and severe hypoglycemia reductions.
  • The guidance provides an update on the state of technology and improvements to functional features of the pump.
  • Medicare no longer covers CGM for pump therapy in patients over 65

Grunberger G, et al "Consensus statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force" Presented at the 2014 AACE meeting. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 29 May, 2014 and appeared in  MedicationBG ControlType 1 DiabetesMedical DevicesInsulinGlucose MonitoringIssue 731

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

2015 Most Popular Articles:

Coffee Consumption Proves Potential in Reducing Type 2 Diabetes Risk
Posted August 07, 2015
Impaired Glucose Uptake in the Brain May Increase Alzheimer's Disease Risk
Posted August 07, 2015
Ketoacidosis Not as Great as Thought in Diabetes Patients Taking Invokana
Posted August 13, 2015
First Non-Surgical Weight Loss Procedure for Mild-to-Moderate Obesity
Posted August 07, 2015
Impact of Switching Insulin Glargine to Insulin Detemir in T2 Patients
Posted August 14, 2015
SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy
Posted August 14, 2015
GLP-1 Agonist Semaglutide Completes Phase III Trial with Positive Results
Posted August 07, 2015
Soybean Oil Causes More Obesity and Diabetes Than Fructose
Posted August 20, 2015
Diabetes Combination Drug LixiLan Meets Main Target in Late Stage Trial
Posted August 07, 2015
Two New Possible Methods for Diagnosing and Monitoring Diabetes
Posted August 07, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Vickie Driver, DPM, MS, FACFAS

Category: Wound Care
Credits: 1.0